ICPT
Ameriprise’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-12,399
| Closed | -$241K | – | 4026 |
|
2023
Q3 | $241K | Sell |
12,399
-36,870
| -75% | -$717K | ﹤0.01% | 3645 |
|
2023
Q2 | $545K | Buy |
49,269
+6,055
| +14% | +$67K | ﹤0.01% | 3398 |
|
2023
Q1 | $580K | Buy |
43,214
+1,514
| +4% | +$20.3K | ﹤0.01% | 3365 |
|
2022
Q4 | $510K | Sell |
41,700
-47,493
| -53% | -$581K | ﹤0.01% | 3400 |
|
2022
Q3 | $1.24M | Sell |
89,193
-5,918
| -6% | -$82.5K | ﹤0.01% | 3009 |
|
2022
Q2 | $1.31M | Buy |
95,111
+7,990
| +9% | +$110K | ﹤0.01% | 2997 |
|
2022
Q1 | $1.42M | Buy |
87,121
+9,428
| +12% | +$153K | ﹤0.01% | 3063 |
|
2021
Q4 | $1.27M | Buy |
77,693
+57,168
| +279% | +$931K | ﹤0.01% | 3145 |
|
2021
Q3 | $305K | Sell |
20,525
-23,593
| -53% | -$351K | ﹤0.01% | 3563 |
|
2021
Q2 | $881K | Buy |
44,118
+20,709
| +88% | +$414K | ﹤0.01% | 3266 |
|
2021
Q1 | $540K | Sell |
23,409
-1,187,123
| -98% | -$27.4M | ﹤0.01% | 3367 |
|
2020
Q4 | $29.9M | Buy |
1,210,532
+349,254
| +41% | +$8.63M | 0.01% | 988 |
|
2020
Q3 | $35.7M | Buy |
861,278
+694,080
| +415% | +$28.8M | 0.01% | 778 |
|
2020
Q2 | $8.01M | Sell |
167,198
-229,836
| -58% | -$11M | ﹤0.01% | 1699 |
|
2020
Q1 | $25M | Buy |
397,034
+129,804
| +49% | +$8.17M | 0.01% | 826 |
|
2019
Q4 | $33.1M | Buy |
267,230
+71,818
| +37% | +$8.9M | 0.01% | 888 |
|
2019
Q3 | $13M | Buy |
195,412
+68,428
| +54% | +$4.54M | 0.01% | 1487 |
|
2019
Q2 | $10.1M | Buy |
126,984
+92,313
| +266% | +$7.33M | ﹤0.01% | 1729 |
|
2019
Q1 | $3.87M | Buy |
34,671
+160
| +0.5% | +$17.9K | ﹤0.01% | 2387 |
|
2018
Q4 | $3.48M | Sell |
34,511
-18,003
| -34% | -$1.81M | ﹤0.01% | 2356 |
|
2018
Q3 | $6.64M | Buy |
52,514
+10,113
| +24% | +$1.28M | ﹤0.01% | 2164 |
|
2018
Q2 | $3.56M | Sell |
42,401
-46,947
| -53% | -$3.94M | ﹤0.01% | 2458 |
|
2018
Q1 | $5.5M | Sell |
89,348
-62,434
| -41% | -$3.84M | ﹤0.01% | 2104 |
|
2017
Q4 | $8.87M | Sell |
151,782
-1,298,730
| -90% | -$75.9M | ﹤0.01% | 1702 |
|
2017
Q3 | $84.2M | Sell |
1,450,512
-1,126,217
| -44% | -$65.4M | 0.04% | 406 |
|
2017
Q2 | $312M | Sell |
2,576,729
-313,813
| -11% | -$38M | 0.16% | 145 |
|
2017
Q1 | $327M | Buy |
2,890,542
+382,642
| +15% | +$43.3M | 0.17% | 135 |
|
2016
Q4 | $272M | Sell |
2,507,900
-118,100
| -4% | -$12.8M | 0.15% | 140 |
|
2016
Q3 | $432M | Sell |
2,626,000
-380,293
| -13% | -$62.6M | 0.24% | 87 |
|
2016
Q2 | $429M | Buy |
3,006,293
+74,253
| +3% | +$10.6M | 0.25% | 83 |
|
2016
Q1 | $377M | Buy |
2,932,040
+68,971
| +2% | +$8.86M | 0.22% | 96 |
|
2015
Q4 | $428M | Buy |
2,863,069
+1,016,175
| +55% | +$152M | 0.25% | 86 |
|
2015
Q3 | $306M | Buy |
1,846,894
+350,815
| +23% | +$58.2M | 0.19% | 108 |
|
2015
Q2 | $361M | Buy |
1,496,079
+672,471
| +82% | +$162M | 0.21% | 108 |
|
2015
Q1 | $232M | Buy |
823,608
+745,603
| +956% | +$210M | 0.13% | 156 |
|
2014
Q4 | $12.2M | Sell |
78,005
-12,554
| -14% | -$1.96M | 0.01% | 1343 |
|
2014
Q3 | $21.4M | Buy |
90,559
+29,431
| +48% | +$6.97M | 0.01% | 924 |
|
2014
Q2 | $14.5M | Buy |
61,128
+43,126
| +240% | +$10.2M | 0.01% | 1260 |
|
2014
Q1 | $5.94M | Buy |
18,002
+2,353
| +15% | +$776K | ﹤0.01% | 1903 |
|
2013
Q4 | $1.07M | Buy |
15,649
+3,652
| +30% | +$249K | ﹤0.01% | 2639 |
|
2013
Q3 | $828K | Buy |
11,997
+11,606
| +2,968% | +$801K | ﹤0.01% | 2737 |
|
2013
Q2 | $18K | Buy |
+391
| New | +$18K | ﹤0.01% | 4359 |
|